1
|
Ferrari P, Jenab M, Norat T, Moskal A, Slimani N, Olsen A, Tjønneland A, Overvad K, Jensen MK, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Rohrmann S, Linseisen J, Boeing H, Bergmann M, Kontopoulou D, Trichopoulou A, Kassapa C, Masala G, Krogh V, Vineis P, Panico S, Tumino R, Gils CHV, Peeters P, Bueno-de-Mesquita HB, Ocké MC, Skeie G, Lund E, Agudo A, Ardanaz E, López DC, Sanchez MJ, Quirós JR, Amiano P, Berglund G, Manjer J, Palmqvist R, Guelpen BV, Allen N, Key T, Bingham S, Mazuir M, Boffetta P, Kaaks R, Riboli E. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 2007; 121:2065-2072. [PMID: 17640039 DOI: 10.1002/ijc.22966] [Citation(s) in RCA: 178] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Alcohol consumption may be associated with risk of colorectal cancer (CRC), but the epidemiological evidence for an association with specific anatomical subsites, types of alcoholic beverages and current vs. lifetime alcohol intake is inconsistent. Within the European Prospective Investigation into Cancer and Nutrition (EPIC), 478,732 study subjects free of cancer at enrolment between 1992 and 2000 were followed up for an average of 6.2 years, during which 1,833 CRC cases were observed. Detailed information on consumption of alcoholic beverages at baseline (all cases) and during lifetime (1,447 CRC cases, 69% of the cohort) was collected from questionnaires. Cox proportional hazard models were used to examine the alcohol-CRC association. After adjustment for potential confounding factors, lifetime alcohol intake was significantly positively associated to CRC risk (hazard ratio, HR=1.08, 95%CI=1.04-1.12 for 15 g/day increase), with higher cancer risks observed in the rectum (HR=1.12, 95%CI=1.06-1.18) than distal colon (HR=1.08, 95%CI=1.01-1.16), and proximal colon (HR=1.02, 95%CI=0.92-1.12). Similar results were observed for baseline alcohol intake. When assessed by alcoholic beverages at baseline, the CRC risk for beer (HR=1.38, 95%CI=1.08-1.77 for 20-39.9 vs. 0.1-2.9 g/day) was higher than wine (HR=1.21, 95%CI=1.02-1.44), although the two risk estimates were not significantly different from each other. Higher HRs for baseline alcohol were observed for low levels of folate intake (1.13, 95%CI=1.06-1.20 for 15 g/day increase) compared to high folate intake (1.03, 95%CI=0.98-1.09). In this large European cohort, both lifetime and baseline alcohol consumption increase colon and rectum cancer risk, with more apparent risk increases for alcohol intakes greater than 30 g/day.
Collapse
Affiliation(s)
- Pietro Ferrari
- International Agency for Research on Cancer (IARC-WHO), Lyon, France
| | - Mazda Jenab
- International Agency for Research on Cancer (IARC-WHO), Lyon, France
| | - Teresa Norat
- Department of Epidemiology and Public Health, Imperial College London, London, United Kingdom
| | - Aurelie Moskal
- International Agency for Research on Cancer (IARC-WHO), Lyon, France
| | - Nadia Slimani
- International Agency for Research on Cancer (IARC-WHO), Lyon, France
| | - Anja Olsen
- Institute of Cancer Epidemiology, The Danish Cancer Society, Copenhagen, Denmark
| | - Anne Tjønneland
- Institute of Cancer Epidemiology, The Danish Cancer Society, Copenhagen, Denmark
| | - Kim Overvad
- Department of Clinical Epidemiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
| | - Majken K Jensen
- Department of Clinical Epidemiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
| | | | | | - Sophie Morois
- Nutrition, Hormones and Cancer Unit, E3N, EMT, Institut Gustave Roussy, Villejuif Cedex, France
| | - Sabine Rohrmann
- Deutsches Krebsforschungszentrum/German Cancer Research Centre, Klinische Epidemiologie/Clinical Epidemiology, C020, AG Ernährungsepidemiologie/Nutritional Epidemiology, Heidelberg, Germany
| | - Jakob Linseisen
- Deutsches Krebsforschungszentrum/German Cancer Research Centre, Klinische Epidemiologie/Clinical Epidemiology, C020, AG Ernährungsepidemiologie/Nutritional Epidemiology, Heidelberg, Germany
| | - Heiner Boeing
- Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany
| | - Manuela Bergmann
- Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany
| | - Dimitra Kontopoulou
- Department of Hygiene and Epidemiology, Medical School, University of Athens, Greece
| | - Antonia Trichopoulou
- Department of Hygiene and Epidemiology, Medical School, University of Athens, Greece
| | - Christina Kassapa
- Department of Hygiene and Epidemiology, Medical School, University of Athens, Greece
| | - Giovanna Masala
- Molecular and Nutritional Epidemiology Unit, CSPO-Scientific Institute of Tuscany, Florence, Italy
| | - Vittorio Krogh
- Nutritional Epidemiology Unit, National Cancer Institute, Milan, Italy
| | - Paolo Vineis
- Department of Epidemiology and Public Health, Imperial College, London, United Kingdom
- Department of Biomedical Sciences and Human Oncology, University of Torino, Italy
| | - Salvatore Panico
- Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
| | - Rosario Tumino
- Cancer Registry, Azienda Ospedaliera "Civile M.P. Arezzo," Ragusa, Italy
| | - Carla H van Gils
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands
| | - Petra Peeters
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands
| | - H Bas Bueno-de-Mesquita
- Cancer Epidemiology, Centre for Nutrition and Health, National Institute of Public Health and the Environment, Bilthoven, The Netherlands
| | - Marga C Ocké
- Cancer Epidemiology, Centre for Nutrition and Health, National Institute of Public Health and the Environment, Bilthoven, The Netherlands
| | - Guri Skeie
- Institute of Community Medicine, University of Tromsø, Tromsø, Norway
| | - Eiliv Lund
- Institute of Community Medicine, University of Tromsø, Tromsø, Norway
| | - Antonio Agudo
- Group of Nutrition, Environmental and Cancer, Department of Epidemiology and Cancer Registry, Catalan Institute of Oncology, Barcelona, Spain
| | - Eva Ardanaz
- Public Health Institute of Navarra, Pamplona, Spain
| | - Dolores C López
- Epidemiology Department, Murcia Health Council, Murcia, Spain
| | | | - José R Quirós
- Public Health and Health Planning Directorate, Asturias, Spain
| | - Pilar Amiano
- Public Health Division of Gipuzkoa, Health Department of the Basque Country, Donostia-San Sebastian, Spain
| | - Göran Berglund
- Institutionen för Kliniska Vetenskaper, Kirurgiska Kliniken, Universitetssjukhuset MAS, Malmö, Sweden
| | - Jonas Manjer
- Institutionen för Kliniska Vetenskaper, Kirurgiska Kliniken, Universitetssjukhuset MAS, Malmö, Sweden
| | - Richard Palmqvist
- Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden
| | | | - Naomi Allen
- Cancer Research UK Epidemiology Unit, University of Oxford, Oxford, United Kingdom
| | - Tim Key
- Cancer Research UK Epidemiology Unit, University of Oxford, Oxford, United Kingdom
| | - Sheila Bingham
- MRC Centre for Nutritional Epidemiology in Cancer Prevention and Survival, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
| | - Mathieu Mazuir
- International Agency for Research on Cancer (IARC-WHO), Lyon, France
| | - Paolo Boffetta
- International Agency for Research on Cancer (IARC-WHO), Lyon, France
| | - Rudolf Kaaks
- Deutsches Krebsforschungszentrum/German Cancer Research Centre, Klinische Epidemiologie/Clinical Epidemiology, C020, AG Ernährungsepidemiologie/Nutritional Epidemiology, Heidelberg, Germany
| | - Elio Riboli
- Department of Epidemiology and Public Health, Imperial College London, London, United Kingdom
| |
Collapse
|